NZX50 slides to nine-month low

NZX50 slides to nine-month low
A new drug has weighed on Fisher and Paykel's shares. (Image: Getty)
Graham Skellern
A weight-reducing drug is causing trouble for Fisher and Paykel Healthcare as the New Zealand sharemarket chalked up its sixth successive fall.The S&P/NZX 50 Index was on a downward slide all day and closed at 11,344.11, down 82.73 points or 0.72% – its lowest level for nine months.The index has now fallen 1.8% for the year and was at 11308.31 points on November 28.There were 42 gainers and 84 decliners on the main board, with 28.19 million shares worth $102.5m changing hands.Under pressureMarket heavyweight Fisher and Paykel Healthca...

More Markets

Warehouse CEO ‘very soon’ as firm orbits sun without one
Retail

Warehouse CEO ‘very soon’ as firm orbits sun without one

Group chair Joan Withers is making sure she gets this one right.

Why IkeGPS is amped to win in the US
Markets

Why IkeGPS is amped to win in the US

Multibillion-dollar infrastructure spend is significant tailwind for Colorado-based firm.

NZ sharemarket up as Sanford rides the wave
Markets Market Close

NZ sharemarket up as Sanford rides the wave

Sanford’s result was its best in a decade.

Tom Raynel 15 May 2025
Why Xero is loyal to the ASX
Markets

Why Xero is loyal to the ASX

Cloud accounting firm 'happy to show up differently', CEO says.